19 November 2020
Vaccines Webinar: Infection and (Presymptomatic) Transmission of SARS-CoV-2—4 December 2020
![](https://pub.mdpi-res.com/announcement/2281.jpg?1721979229)
You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
SARS-CoV-2 is the newly identified human coronavirus that emerged in December 2019, resulting in severe respiratory disease and viral pneumonia. The disease was later named COVID-19 and has resulted in thousands of deaths to date. Research is underway to understand the transmission and pathogenicity, and to develop treatments and preventative measures for this serious illness. This webinar will discuss the latest advances in understanding the spread of SARS-CoV-2 and its pathogenicity, and will highlight the progress in vaccine and antiviral drug development.
Date: 4 December 2020
Time: 2pm (CET) | 8am (EDT) | 9pm (CST Asia)
Webinar ID: 868 8022 2663
Register for Free Here: https://vaccines-1.sciforum.net/
Chair:
|
Dr. Hatem Elshabrawy Guest Editor of “Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19” |
Interests: Development of antiviral small molecules and antibodies |
Speakers:
|
Dr. Francesco De Sanctis |
Presentation: " Deciphering the state of immune silence in fatal COVID-19 patients"" |
|
|
Prof. Maria Anagnostouli |
Presentation: " Host HLA-genotype and COVID-19 infection. Impact on severity, clinical outcome and therapeutics " |
|
|
Dr. Hussin Rothan |
Presentation: "The widespread of SARS-CoV-2 virus could be attributed to the genetic variation in the viral spikes" |
|
|
Dr. Kathleen L. Hefferon |
Presentation: "Using Plants to Fight COVID-19" |
For any questions about the webinar, please send an email to [email protected].